Hills Bank & Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $811K | Sell |
1,443
-5
| -0.3% | -$3.21K | 0.04% | 172 |
|
|
2025
Q4 | $980K | Sell |
1,448
-1
| -0.1% | -$681 | 0.06% | 158 |
|
|
2025
Q3 | $926K | Hold |
1,449
| – | – | 0.05% | 160 |
|
|
2025
Q2 | $777K | Sell |
1,449
-30
| -2% | -$14.3K | 0.05% | 169 |
|
|
2025
Q1 | $621K | Sell |
1,479
-1
| -0.1% | -$434 | 0.04% | 174 |
|
|
2024
Q4 | $612K | Hold |
1,480
| – | – | 0.05% | 171 |
|
|
2024
Q3 | $748K | Sell |
1,480
-7
| -0.5% | -$3.4K | 0.06% | 160 |
|
|
2024
Q2 | $724K | Sell |
1,487
-30
| -2% | -$15.1K | 0.06% | 152 |
|
|
2024
Q1 | $819K | Sell |
1,517
-207
| -12% | -$113K | 0.07% | 143 |
|
|
2023
Q4 | $957K | Sell |
1,724
-32
| -2% | -$15K | 0.09% | 127 |
|
|
2023
Q3 | $768K | Sell |
1,756
-317
| -15% | -$158K | 0.09% | 125 |
|
|
2023
Q2 | $1.04M | Sell |
2,073
-378
| -15% | -$181K | 0.13% | 103 |
|
|
2023
Q1 | $1.23M | Sell |
2,451
-52
| -2% | -$24.9K | 0.17% | 89 |
|
|
2022
Q4 | $1.02M | Sell |
2,503
-2
| -0.1% | -$776 | 0.15% | 100 |
|
|
2022
Q3 | $816K | Hold |
2,505
| – | – | 0.12% | 105 |
|
|
2022
Q2 | $878K | Buy |
2,505
+325
| +15% | +$133K | 0.14% | 104 |
|
|
2022
Q1 | $1.19M | Sell |
2,180
-50
| -2% | -$26.3K | 0.17% | 97 |
|
|
2021
Q4 | $1.47M | Sell |
2,230
-25
| -1% | -$15.7K | 0.2% | 86 |
|
|
2021
Q3 | $1.4M | Sell |
2,255
-54
| -2% | -$36.3K | 0.21% | 87 |
|
|
2021
Q2 | $1.46M | Hold |
2,309
| – | – | 0.22% | 83 |
|
|
2021
Q1 | $1.13M | Sell |
2,309
-70
| -3% | -$35.1K | 0.18% | 93 |
|
|
2020
Q4 | $1.19M | Hold |
2,379
| – | – | 0.21% | 88 |
|
|
2020
Q3 | $935K | Sell |
2,379
-10
| -0.4% | -$3.7K | 0.18% | 93 |
|
|
2020
Q2 | $789K | Buy |
2,389
+984
| +70% | +$285K | 0.17% | 101 |
|
|
2020
Q1 | $341K | Sell |
1,405
-59
| -4% | -$15.4K | 0.1% | 110 |
|
|
2019
Q4 | $382K | Hold |
1,464
| – | – | 0.09% | 116 |
|
|
2019
Q3 | $398K | Hold |
1,464
| – | – | 0.1% | 113 |
|
|
2019
Q2 | $403K | Hold |
1,464
| – | – | 0.1% | 112 |
|
|
2019
Q1 | $327K | Hold |
1,464
| – | – | 0.09% | 123 |
|
|
2018
Q4 | $273K | Hold |
1,464
| – | – | 0.08% | 122 |
|
|
2018
Q3 | $366K | Hold |
1,464
| – | – | 0.1% | 116 |
|
|
2018
Q2 | $319K | Hold |
1,464
| – | – | 0.09% | 111 |
|
|
2018
Q1 | $281K | Sell |
1,464
-214
| -13% | -$39.5K | 0.08% | 115 |
|
|
2017
Q4 | $262K | Sell |
1,678
-5
| -0.3% | -$787 | 0.08% | 119 |
|
|
2017
Q3 | $261K | Hold |
1,683
| – | – | 0.08% | 114 |
|
|
2017
Q2 | $272K | Sell |
1,683
-110
| -6% | -$17.9K | 0.09% | 117 |
|
|
2017
Q1 | $277K | Sell |
1,793
-75
| -4% | -$10.3K | 0.09% | 111 |
|
|
2016
Q4 | $219K | Hold |
1,868
| – | – | 0.08% | 125 |
|
|
2016
Q3 | $210K | Buy |
+1,868
| New | +$197K | 0.08% | 126 |
|
Other funds holding IDXX
VCM
VPM
Hills Bank & Trust's IDXX Position: Q1 2026 in Review
Hills Bank & Trust reduced its Idexx Laboratories (IDXX) stake by 0.35% in Q1 2026, selling an estimated $3.21K and leaving 1,443 shares worth $811K. The position accounts for 0.04% of the portfolio, ranked #172.
Hills Bank & Trust first reported a position in IDXX in Q3 2016 and has held it in 39 quarters since. The position peaked at $1.47M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Hills Bank & Trust held 1,443 shares of Idexx Laboratories worth $811K as of Q1 2026.
- Hills Bank & Trust sold 5 Idexx Laboratories shares in Q1 2026, an estimated $3.21K.
- Idexx Laboratories made up 0.04% of Hills Bank & Trust's portfolio in Q1 2026, its #172 holding.
- Hills Bank & Trust first reported a position in Idexx Laboratories in Q3 2016 and has held it in 39 quarters since.
- Hills Bank & Trust's Idexx Laboratories position peaked at $1.47M in Q4 2021.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.